Form 4 for AMRX Amneal Pharmaceuticals, Inc.

Accepted 2024-05-20 00:00:00 ET · period of report 2024-05-16 · accession 0001628280-24-024342 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-05-20	2024-05-16+	AMRX	Autor Deborah M.	Dir	S - Sale	$6.74	-38.0K	116.8K	-25%	-$256.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2024-05-17	S	D	23,447	$6.73	93,402	D	—	—	(F1) The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. (F3) The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.70 to $6.77 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
2	Common	Class A Common Stock	2024-05-16	S	D	14,553	$6.76	116,849	D	—	—	(F1) The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. (F2) The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.79 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.